Randomized Controlled Trials 7: On Contamination and Estimating the Actual Treatment Effect

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Evidence-Based Medicine

Background:

• Intention-to-treat (ITT) analysis is standard for randomized controlled trials (RCTs).
• High rates of non-adherence (dropout/drop-in) can lead to underestimation of true treatment effects.
• Contamination between treatment groups poses a challenge to accurate efficacy assessment.

Purpose of the Study:

• To explore methods for addressing non-adherence and contamination in RCTs.
• To evaluate strategies for preserving the integrity of intention-to-treat (ITT) analysis.
• To identify analytical approaches for estimating "prescribed efficacy".

Main Methods:

• Discusses trial design strategies to minimize non-adherence and contamination.
• Reviews advanced statistical methods including censoring, lag censoring, and inverse probability of censoring weights (IPCW).
• Highlights contamination-adjusted intent-to-treat analysis and accelerated failure time models.

Main Results:

• These advanced methods can mitigate bias introduced by non-adherence.
• Contamination-adjusted ITT analysis provides a more accurate measure of treatment effect.
• The discussed techniques help in assessing "prescribed efficacy".

Conclusions:

• Addressing non-adherence and contamination is crucial for valid RCT results.
• Specialized analytical techniques enhance the estimation of treatment efficacy.
• Accurate efficacy assessment supports informed clinical decision-making.